NASDAQ: LRMR - Larimar Therapeutics, Inc.

Yield per half year: -75.61%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Larimar Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., биотехнологическая компания клинической стадии, специализируется на разработке методов лечения редких заболеваний с использованием своей новой технологической платформы пептидов, проникающих в клетки. Его ведущим продуктом-кандидатом является CTI-1601, который находится на стадии 2 клинических испытаний для лечения атаксии Фридрейха, редкого, прогрессирующего и смертельного генетического заболевания. Штаб-квартира компании находится в Бала-Синвид, штат Пенсильвания.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2014-06-19
ISIN US5171251003
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.larimartx.com
Цена ао 2.25
Change price per day: 0% (1.81)
Change price per week: -3.21% (1.87)
Change price per month: -30.65% (2.61)
Change price per 3 month: -47.99% (3.48)
Change price per half year: -75.61% (7.42)
Change price per year: -75.21% (7.3)
Change price per 3 year: -46.76% (3.4)
Change price per 5 year: +172.92% (0.6632)
Change price per year to date: -56.49% (4.16)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 2.3 6
P/E 0 0
EV/EBITDA -4.02 0
Total: 3.25

Efficiency

Title Value Grade
ROA, % -38.51 0
ROE, % -45.21 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1338 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 79.15 8
Yield EPS, % -66.36 0
Total: 4.4
More

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 16941357 26.62
Blue Owl Capital Holdings LP 3414468 5.37
Verition Fund Management, LLC 2811131 4.42
Janus Henderson Group PLC 2641065 4.15
Blackrock Inc. 1668045 2.62
Vanguard Group Inc 1455243 2.29
Adage Capital Partners GP L.L.C. 1276680 2.01
Mangrove Partners 805815 1.27
Woodline Partners LP 796226 1.25
Stempoint Capital LP 783172 1.23



Head Job title Payment Year of birth
Dr. Carole S. Ben-Maimon M.D. CEO, President & Director 845.63k 1959 (66 years)
Mr. Michael Celano CPA Secretary & CFO 562.62k 1959 (66 years)
Mr. John Berman Vice President of Finance & Administration N/A
Ms. Jennifer Spokes Johansson Vice President of Legal & Compliance N/A
Dr. Gopi Shankar M.B.A., Ph.D. Chief Development Officer N/A 1971 (54 years)
Mr. Francis Michael Conway CPA VP & Controller N/A
Dr. Russell G. Clayton Sr., D.O, D.O. Chief Medical Officer 1961 (64 years)

Address: United States, Bala Cynwyd. PA, Three Bala Plaza East - open in Google maps, open in Yandex maps
Website: https://www.larimartx.com